Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 30,646 Cr.
- Current Price ₹ 730
- High / Low ₹ 858 / 576
- Stock P/E 151
- Book Value ₹ 93.6
- Dividend Yield 0.00 %
- ROCE 9.50 %
- ROE 11.3 %
- Face Value ₹ 2.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 21.9% of last 10 years
Cons
- Stock is trading at 7.79 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last 3 years: -6.20%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | 4,596 | |
| Sales growth | +11% | +17% | +38% | +22% | +18% | +24% | +33% | +14% | +21% | +29% | +35% | |
| 403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,587 | 1,850 | 2,242 | 3,090 | 3,708 | |
| Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 793 | 815 | 889 |
| OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% | 21% | 19% |
| 5 | 3 | 37 | 6 | 5 | 9 | 27 | 41 | 13 | 43 | 17 | 56 | |
| Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 55 | 100 | 215 | 274 |
| Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 147 | 177 | 283 | 385 |
| Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 460 | 558 | 334 | 286 |
| Tax % | 32% | 37% | 126% | 223% | 18% | 26% | 25% | 25% | 27% | 26% | 28% | |
| 28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | 197 | |
| EPS in Rs | 0.76 | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 | 6.03 | 5.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 4% |
| 3 Years: | -9% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 25% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 | 84 |
| Reserves | 193 | 255 | -209 | 466 | 524 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 | 3,848 |
| 256 | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 1,355 | 2,562 | 4,253 | 3,538 | |
| 146 | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 636 | 990 | 1,190 | 1,442 | |
| Total Liabilities | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,691 | 8,912 |
| 515 | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | 5,710 | 6,324 | |
| CWIP | 2 | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 | 518 |
| Investments | 11 | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 | 103 | 413 |
| 137 | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 629 | 1,028 | 1,271 | 1,657 | |
| Total Assets | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,691 | 8,912 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 | 511 | |
| -41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 | -1,452 | |
| -65 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | 940 | |
| Net Cash Flow | -11 | 5 | 3 | -3 | 32 | 12 | -26 | 36 | -15 | 9 | -1 |
| Free Cash Flow | 61 | -18 | 49 | 57 | 150 | 262 | 154 | -140 | -125 | -380 | -902 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 88% | 80% | 192% | 195% | 102% | 104% | 86% | 87% | 102% | 91% | 81% |
Ratios
Consolidated / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 59 | 59 | 49 | 43 | 30 | 28 | 42 | 43 | 48 | 52 |
| Inventory Days | 36 | 43 | 46 | 47 | 44 | 30 | 37 | ||||
| Days Payable | 194 | 207 | 215 | 181 | 177 | 167 | 133 | ||||
| Cash Conversion Cycle | -111 | -105 | -110 | -85 | -91 | -106 | -67 | 42 | 43 | 48 | 52 |
| Working Capital Days | 11 | 26 | -333 | -15 | -15 | -31 | -3 | 8 | -5 | -29 | -37 |
| ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% | 17% | 15% | 10% |
Insights
In beta| Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| ARPOB (Average Revenue Per Occupied Bed) Rs |
|
||||||||
| Bed Occupancy % |
|||||||||
| Total Bed Capacity Beds |
|||||||||
| ALOS (Average Length of Stay) Days |
|||||||||
| IP Volume (Inpatient Volume) Patients |
|||||||||
| OP Volume (Outpatient Volume) Patients |
|||||||||
| Operational Beds Beds |
|||||||||
| ARPP (Average Revenue Per Patient) Rs |
|||||||||
| Specialty Mix - Cardiac Sciences % of revenue |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
KIMS Swastha Private Limited ('KSPL'), Wholly-Owned Subsidiary Of The Krishna Institute Of Medical Sciences Limited ('Company') Has Entered Into An Operations And Management Agreement With LOVR Institute Of Medical Sciences Limited
- KIMS subsidiary signed 10-year O&M agreement for Thrissur’s Westfort Hi-Tech Hospital, effective 4 Nov 2026.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- KIMS schedules Investec Pune Confluence group meeting on November 19, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- KIMS to attend Avendus Spark INDX Annual Investor Conference on November 17, 2026 in Mumbai.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of Q2 FY27 investor/analyst conference call dated November 5, 2026 posted online.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2022
from nse
Concalls
-
Nov 2026Transcript PPT REC
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Nov 2025PPT
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022PPT
-
May 2022Transcript PPT
-
May 2022PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021PPT
-
Aug 2021Transcript PPT
Regional Leadership:[1][2]
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, offering multi-disciplinary integrated healthcare with a focus on tertiary and quaternary care at affordable cost.
The group today currently runs 26 hospitals across 5 states - Telangana, Andhra Pradesh, Maharashtra, Karnataka, and Kerala (with a
6th state, Tamil Nadu, on the drawing board
for Chennai)- and offers 40+ specialty services, including Cardiac Sciences, Oncology, Neuro sciences, Organ Transplantation, and Maternal
& Child Health.